English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 15 July 2022, 14:10 HKT/SGT
Share:
    

Source: Malaysian Genomics Resource Centre Bhd
Malaysian Genomics Appoints New Chairman
Former MOH Secretary General Dato' Seri Dr Chen Chaw Min takes over effective 15 July 2022

PETALING JAYA, Malaysia, July 15, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors.

Dato' Seri Dr Chen Chaw Min, Independent Non-Executive Chairman of Malaysian Genomics

Dato' Alvin Joseph, Executive Director of Malaysian Genomics

The appointment is effective 15 July 2022, following the resignation of Tan Sri Ahmad bin Mohd Don on 12 July 2022.

Dato' Seri Dr Chen, who was appointed to the Board on 3 August 2021, was with the Malaysian civil service from 1988 until his retirement in February 2021. He was the Secretary-General of the Ministry of Health (MOH) from July 2015 until his retirement and has also served in various capacities in the Ministry of Finance (MOF) from 1990 until 2014.

Dato' Seri Dr. Chen said, "I feel privileged to take on this role at such an exciting time for Malaysian Genomics. The Group is currently expanding downstream to healthcare services and pioneering holistic care which will benefit many for the years to come, I hope that my experience in both MOH and MOF will be able to add knowledge and insights to support the Company's growth."

Dato' Alvin Joseph, Executive Director of Malaysian Genomics said, "We welcome Dato' Seri Chen to the Board of Malaysian Genomics as Chairman of the Board and look forward to working with him in ensuring proper governance in our business operations. His extensive experience in the civil service and in particular in MOH will be invaluable to us."

"We would like to extend our thanks to Tan Sri Ahmad bin Mohd Don for his invaluable contributions and guidance to the Board in executing their duties. We wish him all the best in his future endeavours."

Dato' Seri Dr Chen obtained a doctorate in finance from Universiti Putra Malaysia in 2005. He received an MBA (Finance) from University of Illinois in 1997 and a Bachelor in Surveying from University of Technology, Malaysia, in 1985.

Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/

Topic: Executive appointment
Source: Malaysian Genomics Resource Centre Bhd

Sectors: Daily News, BioTech, Healthcare & Pharm, Local Biz
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Malaysian Genomics Resource Centre Bhd Related News
Aug 29, 2023 13:00 HKT/SGT
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
May 15, 2023 18:00 HKT/SGT
Malaysian Genomics Inks Agreement in Expansion to Bangladesh
Feb 27, 2023 13:00 HKT/SGT
Malaysian Genomics to Boost Play on the Football Pitch
Feb 24, 2023 17:30 HKT/SGT
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
Feb 24, 2023 13:30 HKT/SGT
Malaysian Genomics to Collaborate on Cannabinoid R&D
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575